Role of SPECT/CT in sentinel lymph node detection in patients with breast cancer

Clinical Nuclear Medicine

Volumn 39, Issue 5, 2014, Pages 431-436

  Vercellino, Laetitia ^a,b   Ohnona, Jessica ^a,b   Groheux, David ^a,b   Slama, Abdelhak ^a,b   Colletti, Patrick M ^c   Chondrogiannis, Sotirios ^d   Merlet, Pascal ^a,b   Toubert, Marie Elisabeth ^a,b   Rubello, Domenico ^d  

^a SAINT LOUIS HOSPITAL   (France)

^b INSERM   (France)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d SANTA MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

Author keywords

breast cancer; sentinel lymph node; SPECT CT

Indexed keywords

COBALT 57; TECHNETIUM 99M; TRACER;

AXILLARY LYMPH NODE; BREAST CANCER; CANCER PATIENT; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; HUMAN; LYMPH NODE METASTASIS; LYMPHATIC DRAINAGE; LYMPHOSCINTIGRAPHY; MEDICAL LITERATURE; MEDLINE; RADIATION DOSE; REVIEW; SENTINEL LYMPH NODE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SURGICAL APPROACH; SYSTEMATIC REVIEW; BREAST NEOPLASMS; FEMALE; LYMPH NODE; META ANALYSIS; MULTIMODAL IMAGING; PATHOLOGY; RADIOGRAPHY; SCINTISCANNING; SENTINEL LYMPH NODE BIOPSY; SURGERY;

BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODES; MULTIMODAL IMAGING; SENTINEL LYMPH NODE BIOPSY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84898538561     PISSN: 03639762     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0b013e31829af8c0     Document Type: Review

References (37)

1. Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancerVa multicenter validation study. N Engl J Med. 1998;339:941-946.
2. Schwartz GF, Giuliano AE, Veronesi U. Consensus Conference Committee. Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19-22, 2001, Philadelphia, Pennsylvania. Cancer. 2002;94:2542-2551.
3. D'Angelo-Donovan DD, Dickson-Witmer D, Petrelli NJ. Sentinel lymph node biopsy in breast cancer: a history and current clinical recommendations. Surg Oncol. 2012;21:196-200.
4. Shivers S, Cox C, Leight G, et al. Final results of the Department of Defense multicenter breast lymphatic mapping trial. Ann Surg Oncol. 2002;9: 248-255.
5. McMasters KM, Tuttle TM, Carlson DJ, et al. Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multiinstitutional practice when optimal technique is used. J Clin Oncol. 2000;18: 2560-2566.
6. Martin RC 2nd, Edwards MJ, Wong SL, et al. Practical guidelines for optimal gamma probe detection of sentinel lymph nodes in breast cancer: results of a multi-institutional study. For the University of Louisville Breast Cancer Study Group. Surgery. 2000;128:139-144.
7. Veronesi U, Paganelli G, Viale G, et al. A randomized comparison of sentinelnode biopsy with routine axillary dissection in breast cancer. N Engl J Med. 2003;349:546-553.
8. Giuliano AE, Haigh PI, Brennan MB, et al. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol. 2000;18:2553-2559.
9. Schrenk P, Rieger R, Shamiyeh A, et al. Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer. 2000;88:608-614.
10. Cote RJ, Peterson HF, Chaiwun B, et al. Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International Breast Cancer Study Group. Lancet. 1999;354:896-900.
11. Krag DN, Anderson SJ, Julian TB, et al. Sentinel-lymph-node resection compared with conventional axillary lymph-node dissection in clinically nodenegative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010;11:927-933.
12. Bybel B, Brunken RC, DiFilippo FP, et al. SPECT/CT imaging: clinical utility of an emerging technology. Radiographics. 2008;28:1097-1113.
13. Keidar Z, Israel O, Krausz Y. SPECT/CT in tumor imaging: technical aspects and clinical applications. Semin Nucl Med. 2003;33:205-218.
14. Lerman H, Metser U, Lievshitz G, et al. Lymphoscintigraphic sentinel node identification in patients with breast cancer: the role of SPECT-CT. Eur J Nucl Med Mol Imaging. 2006;33:329-337.
15. Pecking AP, Wartski M, Cluzan RV, et al. SPECT-CT fusion imaging radionuclide lymphoscintigraphy: potential for limb lymphedema assessment and sentinel node detection in breast cancer. Cancer Treat Res. 2007;135:79-84.
16. Husarik DB, Steinert HC. Single-photon emission computed tomography/computed tomography for sentinel node mapping in breast cancer. Semin Nucl Med. 2007;37:29-33.
17. Lerman H, Lievshitz G, Zak O, et al. Improved sentinel node identification by SPECT/CT in overweight patients with breast cancer. J Nucl Med. 2007; 48:201-206.
18. van der Ploeg IM, Valde's Olmos RA, Nieweg OE, et al. The additional value of SPECT/CT in lymphatic mapping in breast cancer and melanoma. J Nucl Med. 2007;48:1756-1760.
19. Gallowitsch HJ, Kraschl P, Igerc I, et al. Sentinel node SPECT-CT in breast cancer. Can we expect any additional and clinically relevant information? Nuklearmedizin. 2007;46:252-256.
20. Mucientes Rasilla J, Farge Balbi'n L, Cardona Arbonie's J, et al. SPECT-CT: a new tool for localisation of sentinel lymph nodes in breast cancer patients. Rev Esp Med Nucl. 2008;27:183-190.
21. Ibusuki M, Yamamoto Y, Kawasoe T, et al. Potential advantage of preoperative three-dimensional mapping of sentinel nodes in breast cancer by a hybrid single photon emission CT (SPECT)/CT system. Surg Oncol. 2010; 19:88-94.
22. van der Ploeg IM, Olmos RA, Kroon BB, et al. The hidden sentinel node and SPECT/CT in breast cancer patients. Eur J Nucl Med Mol Imaging. 2009; 36:6-11.
23. van der Ploeg IM, Nieweg OE, Kroon BB, et al. The yield of SPECT/CT for anatomical lymphatic mapping in patients with breast cancer. Eur J Nucl Med Mol Imaging. 2009;36:903-909.
24. Coffey JP, Hill JC. Breast sentinel node imaging with low-dose SPECT/CT. Nucl Med Commun. 2010;31:107-111.
25. Uren RF, Howman-Giles R, Chung DK, et al. SPECT/CT scans allow precise anatomical location of sentinel lymph nodes in breast cancer and redefine lymphatic drainage from the breast to the axilla. Breast. 2012;21: 480-486.
26. Brouwer OR, Vermeeren L, van der Ploeg IM, et al. Lymphoscintigraphy and SPECT/CT in multicentric and multifocal breast cancer: does each tumour have a separate drainage pattern? Results of a Dutch multicentre study (MULTISENT). Eur J Nucl Med Mol Imaging. 2012;39:1137-1143.
27. van der Ploeg IM, Tanis PJ, Valde's Olmos RA, et al. Breast cancer patients with extra-axillary sentinel nodes only may be spared axillary lymph node dissection. Ann Surg Oncol. 2008;15:3239-3243.
28. Edge SB, Byrd DR, Compton CC, et al. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2010.
29. Berg JW. The significance of axillary node levels in the study of breast carcinoma. Cancer. 1955;8:776-778.
30. Law M, Ma WH, Leung R, et al. Evaluation of patient effective dose from sentinel lymph node lymphoscintigraphy in breast cancer: a phantom study with SPECT/CT and ICRP-103 recommendations. Eur J Radiol. 2012;81: e717-e720.
31. Zakaria S, Degnim AC, Kleer CG, et al. Sentinel lymph node biopsy for breast cancer: how many nodes are enough? J Surg Oncol. 2007;96:554-559.
32. Yi M, Meric-Bernstam F, Ross MI, et al. How many sentinel lymph nodes are enough during sentinel lymph node dissection for breast cancer? Cancer. 2008;113:30-37.
33. Hindié E, Groheux D, Hennequin C, et al. Lymphoscintigraphy can select breast cancer patients for internal mammary chain radiotherapy. Int J Radiat Oncol Biol Phys. 2012;83:1081-1088.
34. van der Ploeg IM, Nieweg OE, van Rijk MC, et al. Axillary recurrence after a tumour-negative sentinel node biopsy in breast cancer patients: a systematic review and meta-analysis of the literature. Eur J Surg Oncol. 2008;34: 1277-1284.
35. Stoffels I, Boy C, Po?ppel T, et al. Association between sentinel lymph node excision with or without preoperative SPECT/CT and metastatic node detection and disease-free survival in melanoma. JAMA. 2012;308:1007-1014.
36. Veronesi U, Galimberti V, Paganelli G, et al. Axillary metastases in breast cancer patients with negative sentinel nodes: a follow-up of 3548 cases. Eur J Cancer. 2009;45:1381-1388.
37. van Wely BJ, van den Wildenberg FJ, Gobardhan P, et al. Axillary recurrences after sentinel lymph node biopsy: a multicentre analysis and follow-up of sentinel lymph node negative breast cancer patients. Eur J Surg Oncol. 2012; 38:925-931.